Prokidney (PROK) EBT Margin (2024 - 2026)

Prokidney (PROK) reported EBT Margin of 18858.85% for Q1 2026, down 261494.0% year-over-year from N/an in Q1 2025, and little changed quarter-over-quarter from 18860.89% in Q4 2025.

Prokidney (PROK) EBT Margin (2024 - 2026) Analysis & Trends

Prokidney (PROK) has 3 years of EBT Margin data on file, last reported at 18858.85% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 18858.85%, down 261494.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 17599.33% (up 3666832.0% YoY), and the FY2025 annual result was 16931.47%, up 19876985.0% from the prior year.
  • EBT Margin held at 18858.85% in Q1 2026 per PROK's latest filing, from 18860.89% in the prior quarter.
  • Over five years, EBT Margin peaked at 16243.91% in Q1 2025 and troughed at 61553.95% in Q4 2024.
  • A 3-year average of 24686.6% and a median of 17600.69% in 2025 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2025 and 2026: EBT Margin surged 4269306 bps in 2025, then plunged 261494 bps in 2026.
  • A 3-year view of EBT Margin shows it stood at 61553.95% in 2024, then jumped by 69 bps to 18860.89% in 2025, then grew by 0 bps to 18858.85% in 2026.
  • Business Quant data shows PROK's EBT Margin at 18858.85% in Q1 2026, 18860.89% in Q4 2025, and 16259.45% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 6.40%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 41.95%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Prokidney 259.01 Mn 1.55 Bn - -18,858.85%

Historic Data

Download Data
DateValue
Mar 31, 2026 -18,858.85%
Dec 31, 2025 -18,860.89%
Sep 30, 2025 -16,259.45%
Jun 30, 2025 -16,342.53%
Mar 31, 2025 -16,243.91%
Dec 31, 2024 -61,553.95%